LifeStance Health Group Inc. (LFST)
NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LFST stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.60B
- P/E (TTM)
- 93.15
- Forward P/E
- 28.11
- EPS (TTM)
- $0.13
- Dividend yield
- None
- 52-week range
- 4.77 – 13.56
- Day range
- 11.96 – 12.30
- Volume / Avg
- 3.65M / 4.37M
- Beta
- —
- Shares outstanding
- 380.15M
- Next earnings
- Nov 5, 2026
52-week range
LFST stock today
LifeStance Health Group (LFST) closed at $12.11 on Oct 7, down 0.08% (-$0.01), versus the S&P 500's 0.22% decline. Shares are 10.7% below their 52-week high of $13.56, set on Sep 14, 2026 and 153.9% above the 52-week low of $4.77, near the top of the past year's range. LFST is up 72.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 119.0%.
At 93.2x trailing earnings, LifeStance Health Group trades above the peer-group median of 19.8x. Its forward P/E of 28.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. LifeStance Health Group's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About LifeStance Health Group
Company profileLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. David Patrick Bourdon
- Headquarters
- Scottsdale, AZ
- Employees
- 8,542
- IPO year
- 2021
- Website
- lifestance.com
Financial highlights
Full financialsIn fiscal 2025, LifeStance Health Group generated $1.42 billion in revenue, up 13.9% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $9.7 million, for a net margin of 0.7% versus a median of -17.6% in the prior 5 years. Operating margin was 1.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.54M | $667.51M |
| Growth | +13.85% | +18.50% | +22.82% | +28.77% | +214.10% |
| Net income | $9.66M | $-57.44M | $-186.26M | $-215.56M | $-307.20M |
| EPS (diluted) | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
Analyst forecast
ForecastConsensus (11 analysts)
buy
Avg. price target
$14.40+18.91%
- Strong buy 2
- Buy 7
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.03
- Last reported (Q2 2026)
- Aug 6, 2026
- EPS actual vs est.
- $0.06 vs —
LifeStance Health Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVAHAveanna Healthcare Holdings Inc. | 12.31 | +0.74% | $2.69B | vs LFST |
| PRVAPrivia Health Group Inc. | 20.30 | +0.10% | $2.59B | vs LFST |
| HIMSHims & Hers Health Inc. Class A | 29.54 | +0.24% | $6.89B | vs LFST |
| ADUSAddus HomeCare Corporation | 113.27 | +0.10% | $2.12B | vs LFST |
| WGSGeneDx Holdings Corp. Class A | 68.53 | -4.18% | $2.04B | vs LFST |
| ALPSALPS Group Inc | 0.3444 | -10.71% | $57.31M | vs LFST |
| EUDAEUDA Health Holdings Limited | 19.04 | -0.58% | $57.01M | vs LFST |
| DCGODocGo Inc. | 0.345 | -4.70% | $34.15M | vs LFST |
Indexes, lists and sector
LifeStance Health Group stock FAQ
What is LifeStance Health Group's stock price today?
LFST last traded at $12.11 as of Oct 7, 4:00 PM EDT, down 0.08% on the day. Prices are delayed at least 15 minutes.
When is LifeStance Health Group's next earnings date?
LifeStance Health Group is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.03.
What is LFST's P/E ratio?
LFST trades at a trailing P/E ratio of 93.15 and a forward P/E of 28.11, compared with a median of 19.8 for its closest peers.
Who is LifeStance Health Group's CEO?
Mr. David Patrick Bourdon is the chief executive officer of LifeStance Health Group Inc., which has about 8,542 employees.
What is the LFST 52-week high?
The 52-week high for LFST is $13.56 and the 52-week low is $4.77. The stock is currently 10.7% below its high.